Healthcare
AmerisourceBergen Corporation(ABC)
Live Price
Offline$179.98
-0.23% today
1Y Change
—
Window
No data
- Market Cap
- $36.15B
- Revenue Growth
- +9.3%
- EPS Growth
- +5.5%
- Dividend Yield
- 0.8%
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
AmerisourceBergen Corporation (ABC) is a Healthcare stock with a market cap of $36.15B and listed on NYSE. The stock last traded around $179.98. Baseline metrics include revenue growth of +9.3%, EPS growth of +5.5%, a dividend yield of 0.8%. What stands out right now is revenue +9.3%, EPS +5.5%, free cash flow +7.0% with operating margin 1.2% and ROIC 13.8%. The dividend is present but secondary, with a yield around 0.8%. Valuation already assumes a fairly strong business story at P/E 36.3 and price/sales 0.2. Stock Foundry combines ABC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+9.3% vs +6.2% peer median
Operating Margin
Below sector median
+1.2% vs +19.4% peer median
P/E
Below sector median
36.3 vs 101.5 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Feb 4, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +9.3% and EPS at +5.5%, with operating margin around 1.2%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 0.8%, which matters if the thesis depends on income as much as growth.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ABC
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ABC Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ABC and SPY.
Company Overview
AmerisourceBergen Corporation
New York Stock Exchange
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
- Leadership
- Steven H. Collis
- IPO Date
- Apr 4, 1995
- Employees
- 46.0k
- Street Address
- 1 West First Avenue
- Mailing
- Conshohocken, PA, 19428-1800
- Region
- Conshohocken, PA, US
- Reporting Currency
- USD
- Investor Line
- 610 727 7000
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 36.3
- EV/EBITDA
- 17.1
- Price/Sales
- 0.2
- Price/Book
- 30.9
Growth
- Revenue
- +9.3%
- EPS
- +5.5%
- Free Cash Flow
- +7.0%
Profitability
- Gross Margin
- 3.3%
- Operating Margin
- 1.2%
- Net Margin
- 0.5%
- ROE
- 101.4%
- ROIC
- 13.8%
Balance Sheet
- Debt/Equity
- 4.15
- Current Ratio
- 0.92
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.